Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Pintong Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0747-5765; OpenAlex author ID A5079944301, A5120906759. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 10

  1. E-selectin targeting cascaded ultrasonic cavitation enables liposomes to deeply penetrate pancreatic cancer. Last author DOI 10.1016/j.canlet.2025.218129↗
  2. Reprogramming tumor microenvironment of pancreatic cancer by CAF-targeted sonodynamic therapy combined with chemotherapy. Last author DOI 10.1016/j.mtbio.2026.103065↗
  3. Mechanosensitive channel Piezo1 induces cell apoptosis in pancreatic cancer by ultrasound with microbubbles. Last author DOI 10.1016/j.isci.2022.103733↗
  4. Ultrasound-Enhanced Reactive Oxygen Species Responsive Charge-Reversal Polymeric Nanocarriers for Efficient Pancreatic Cancer Gene Delivery. Last author DOI 10.1021/acsami.1c20030↗
  5. Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer. Last author DOI 10.1186/s12951-022-01459-w↗
  6. Tablet-like TiO2/C nanocomposites for repeated type I sonodynamic therapy of pancreatic cancer. Last author DOI 10.1016/j.actbio.2021.05.029↗
  7. Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer. Last author DOI 10.1016/j.canlet.2021.07.008↗
  8. Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population. Co-author DOI 10.1634/theoncologist.2018-0696↗
  9. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer. Co-author DOI 10.18632/oncotarget.4048↗
  10. Comparison of double contrast-enhanced ultrasound and MDCT for assessing vascular involvement of pancreatic adenocarcinoma: preliminary results correlated with… First author DOI 10.1055/s-0031-1299429↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jifan Chen · 5 shared papers, 2021–2026 · strength 0.85
  2. Yue Hong Song · 4 shared papers, 2021–2022 · strength 0.55
  3. Chenlu Hu · 1 shared paper, 2026 · strength 0.30
  4. Hua Yin · 1 shared paper, 2026 · strength 0.30
  5. 文旭 · 1 shared paper, 2026 · strength 0.29
  6. Jing Cao · 2 shared papers, 2021 · strength 0.26
  7. Xue Wang · 1 shared paper, 2022 · strength 0.15
  8. Cong Zhang · 1 shared paper, 2022 · strength 0.15
  9. Youfeng Xu · 1 shared paper, 2022 · strength 0.14
  10. Tingbo Liang · 2 shared papers, 2015–2019 · strength 0.13
  11. Ying Yuan · 1 shared paper, 2019 · strength 0.08
  12. Xiang Li · 1 shared paper, 2019 · strength 0.08
  13. Qi Zhang · 1 shared paper, 2019 · strength 0.08
  14. Jianying Lou · 1 shared paper, 2019 · strength 0.08
  15. Qichun Wei · 1 shared paper, 2019 · strength 0.08
  16. Yiwen Chen · 1 shared paper, 2019 · strength 0.08
  17. Risheng Que · 1 shared paper, 2019 · strength 0.08
  18. Yinan Shen · 1 shared paper, 2019 · strength 0.08
  19. Xueli Bai · 1 shared paper, 2019 · strength 0.08
  20. Ri‐Sheng Yu · 1 shared paper, 2019 · strength 0.08
  21. Zhaoxia Pu · 1 shared paper, 2015 · strength 0.05
  22. Xia Wu · 1 shared paper, 2012 · strength 0.04
  23. Sergey V. Li · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.